Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,048 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, Pfaller MA, Rex JH, Rinaldi MG, Walsh TJ. Odds FC, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 1998 Feb;42(2):282-8. doi: 10.1128/AAC.42.2.282. Antimicrob Agents Chemother. 1998. PMID: 9527773 Free PMC article.
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.
Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, Rinaldi M, Walsh TJ. Espinel-Ingroff A, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2001 Jun;45(6):1828-35. doi: 10.1128/AAC.45.6.1828-1835.2001. Antimicrob Agents Chemother. 2001. PMID: 11353633 Free PMC article. Clinical Trial.
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Walsh TJ, et al. N Engl J Med. 2002 Jan 24;346(4):225-34. doi: 10.1056/NEJM200201243460403. N Engl J Med. 2002. PMID: 11807146 Free article. Clinical Trial.
Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.
Roilides E, Lyman CA, Filioti J, Akpogheneta O, Sein T, Lamaignere CG, Petraitiene R, Walsh TJ. Roilides E, et al. Among authors: walsh tj. Antimicrob Agents Chemother. 2002 Jun;46(6):1974-6. doi: 10.1128/AAC.46.6.1974-1976.2002. Antimicrob Agents Chemother. 2002. PMID: 12019118 Free PMC article.
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Perfect JR, et al. Among authors: walsh tj. Clin Infect Dis. 2003 May 1;36(9):1122-31. doi: 10.1086/374557. Epub 2003 Apr 22. Clin Infect Dis. 2003. PMID: 12715306 Clinical Trial.
1,048 results